MicroRNA miR-320a and miR-140 inhibit mink enteritis virus infection by repression of its receptor, feline transferrin receptor

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Sun, Jia Zeng ^a   Wang, Jigui ^a   Wang, Shuang ^a   Yuan, Daoli ^a   Li, Zhili ^a   Yi, Bao ^a   Hou, Qiang ^a   Mao, Yaping ^a   Liu, Weiquan ^a  

^a College of Biological Sciences   (China)

Author keywords

Mink enteritis virus (MEV); MiR 140; MiR 320a; Transferrin receptor (TfR)

Indexed keywords

FELIDAE; MINK ENTERITIS VIRUS; MUSTELA;

ANTIVIRUS AGENT; MICRORNA; TRANSFERRIN RECEPTOR; VIRUS RECEPTOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; CAT; CELL LINE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MINK ENTERITIS VIRUS; PHYSIOLOGY; VIRUS ENTRY;

ANIMALS; ANTIVIRAL AGENTS; CATS; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION; MICRORNAS; MINK ENTERITIS VIRUS; RECEPTORS, TRANSFERRIN; RECEPTORS, VIRUS; VIRUS INTERNALIZATION;

EID: 84936888253     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-014-0210-3     Document Type: Article

References (54)

1. Park GS, Best SM, Bloom ME: Two mink parvoviruses use different cellular receptors for entry into CRFK cells. Virology 2005, 340:1-9.
2. Rivera E, Karlsson KA, Bergman R: The propagation of feline panleukopenia virus in microcarrier cell-culture and use of the inactivated virus in the protection of mink against viral-enteritis. Vet Microbiol 1987, 13:371-381.
3. Schofield FW: Virus enteritis in mink. North Amer Vet 1949, 30:651-654.
4. Zhang DL: Studies on isolation, serum-free cultivation and manufacture of mink enteritis virus optimized for vaccine preparation. Biologicals 1997, 25:103-111.
5. Zuo J, Rao J, Xu H, Ma L, Li B, Wang Y, Cai X, Han W, Lei L, Liu B: Analysis of the vp 2 gene sequence of a new mutated mink enteritis parvovirus strain in PR China. Virol J 2010, 7:124-129.
6. Ambros V: The functions of animal microRNAs. Nature 2004, 431:350-355.
7. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell 116, 281-297, 2004). Cell 2007, 131:11-29.
9. Krol J, Loedige I, Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
10. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK: Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 2008, 82:1946-1958.
11. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK: Host-virus interaction: a new role for microRNAs. Retrovirology 2006, 3:68-76.
12. Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L, Nelson JA: A viral microRNA down-regulates multiple cell cycle genes through mRNA 5′ UTRs. PLoS Pathog 2010, 6:e1000967.
13. Motsch N, Pfuhl T, Mrazek J, Barth S, Graesser FA: Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 2007, 4:131-137.
14. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria V, Lalwani M, Pillai B, Mitra D, Brahmachari SK: Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008, 5:117-126.
15. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jäker C, Höck J, Meister G, Grässer FA: Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 2008, 36:666-675.
16. Lung RWM, Tong JHM, Sung YM, Leung PS, Ng DCH, Chau SL, Chan AWH, Ng EKO, Lo KW, To KF: Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009, 11:1174-U1189.
17. Song L, Liu H, Gao S, Jiang W, Huang W: Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol 2010, 84:8849-8860.
18. Sun JZ, Wang J, Yuan D, Wang S, Li Z, Yi B, Mao Y, Hou Q, Liu W: Cellular microRNA miR-181b inhibits replication of mink enteritis virus by repression of non-structural protein 1 translation. PLoS ONE 2013, 8:e81515.
19. Goodman LB, Lyi SM, Johnson NC, Cifuente JO, Hafenstein SL, Parrish CR: Binding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection. J Virol 2010, 84:4969-4978.
20. Hueffer K, Govindasamy L, Agbandje-McKenna M, Parrish CR: Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses. J Virol 2003, 77:10099-10105.
21. Hueffer K, Palermo LM, Parrish CR: Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains. J Virol 2004, 78:5601-5611.
22. Mellman I: Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 1996, 12:575-625.
23. Palermo LM, Hafenstein SL, Parrish CR: Purified feline and canine transferrin receptors reveal complex interactions with the capsids of canine and feline parvoviruses that correspond to their host ranges. J Virol 2006, 80:8482-8492.
24. Parker JSL, Murphy WJ, Wang D, O'Brien SJ, Parrish CR: Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol 2001, 75:3896-3902.
25. Glazov EA, Cottee PA, Barris WC, Moore RJ, Dalrymple BP, Tizard ML: A microRNA catalog of the developing chicken embryo identified by a deep sequencing approach. Genome Res 2008, 18:957-964.
26. Pontius JU, Mullikin JC, Smith DR, Lindblad-Toh K, Gnerre S, Clamp M, Chang J, Stephens R, Neelam B, Volfovsky N, Schäffer AA, Agarwala R, Narfström K, Murphy WJ, Giger U, Roca AL, Antunes A, Menotti-Raymond M, Yuhki N, Pecon-Slattery J, Johnson WE, Bourque G, Tesler G, O'Brien SJ, NISC Comparative Sequencing Program: Initial sequence and comparative analysis of the cat genome. Genome Res 2007, 17:1675-1689.
27. Pontius JU, O'Brien SJ: Genome annotation resource Fields-GARFIELD: a genome browser for Felis catus. J Hered 2007, 98:386-389.
28. Li R, Li Y, Kristiansen K, Wang J: SOAP: short oligonucleotide alignment program. Bioinformatics 2008, 24:713-714.
29. Bland C, Ramsey TL, Sabree F, Lowe M, Brown K, Kyrpides NC, Hugenholtz P: CRISPR Recognition Tool (CRT): a tool for automatic detection of clustered regularly interspaced palindromic repeats. BMC Bioinformatics 2007, 8:209-216.
30. Krueger J, Rehmsmeier M: RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006, 34:W451-W454.
31. Huang HY, Chien CH, Jen KH, Huang HD: RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res 2006, 34:W429-W434.
32. Yang CH, Yue J, Fan M, Pfeffer LM: IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res 2010, 70:8108-8116.
33. Bookout AL, Cummins CL, Mangelsdorf DJ, Pesola JM, Kramer MF: High-throughput real-time quantitative reverse transcription PCR. Curr Protoc Mol Biol 2006, Chapter 15:Unit 15.8.
34. Sun JZ, Wang J, Wang S, Yuan D, Birame BM, Li Z, Yi B, Liu W: MicroRNA profile analysis of a feline kidney cell line before and after infection with mink enteritis virus. Gene 2014, 539:224-229.
35. Otsuka M, Jing Q, Georgel P, New L, Chen J, Mols J, Kang YJ, Jiang Z, Du X, Cook R, Das SC, Pattnaik AK, Beutler B, Han J: Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007, 27:123-134.
36. Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, Hao Q, Liu Y, Gong H, Zhu Y, Liu F, Wu J: A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J 2011, 25:4511-4521.
37. Huang Y, Shen XJ, Zou QA, Wang SP, Tang SM, Zhang GZ: Biological functions of microRNAs: a review. J Physiol Biochem 2011, 67:129-139.
38. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O: A cellular MicroRNA mediates antiviral defense in human cells. Science 2005, 308:557-560.
39. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM: Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 2009, 34:696-709.
40. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M: Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-U913.
41. Aisen P: Transferrin receptor 1. Int J Biochem Cell B 2004, 36:2137-2143.
42. Cheng Y, Zak O, Alsen P, Harrison SC, Walz T: Structure of the human transferrin receptor-transferrin complex. Cell 2004, 116:565-576.
43. Kwok JC, Richardson DR: The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hemat 2002, 42:65-78.
44. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY: Transferrin receptors in human-tissues - their distribution and possible clinical relevance. J Clin Pathol 1983, 36:539-545.
45. Chitambar CR, Massey EJ, Seligman PA: Regulation of transferrin receptor expression on human-leukemic cells during proliferation and induction of differentiation - effects of gallium and dimethylsulfoxide. J Clin Invest 1983, 72:1314-1325.
46. Larrick JW, Cresswell P: Modulation of cell-surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct 1979, 11:579-586.
47. Neckers LM, Trepel JB: Transferrin receptor expression and the control of cell-growth. Cancer Invest 1986, 4:461-470.
48. Op De Beeck A, Caillet-Fauquet P: Viruses and the cell cycle. Prog Cell Cycle Res 1997, 3:1-19.
49. Tattersall P: Replication of the parvovirus MVM 1. Dependence of virus multiplication and plaque-formation on cell-growth. J Virol 1972, 10:586-590.
50. Davidson BL, McCray PB Jr: Current prospects for RNA interference-based therapies. Nat Rev Genet 2011, 12:329-340.
51. Geisbert TW, Lee ACH, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, MacLachlan I: Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 2010, 375:1896-1905.
52. Li BJ, Tang QQ, Cheng D, Qin C, Xie FY, Wei Q, Xu J, Liu YJ, Zheng BJ, Woodle MC, Zhong NS, Lu PY: Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque. Nat Med 2005, 11:944-951.
53. Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, Knipe DM, Lieberman J: An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 2006, 439:89-94.
54. Tompkins SM, Lo CY, Tumpey TM, Epstein SL: Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci U S A 2004, 101:8682-8686.